Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
5.15
-0.41 (-7.37%)
Apr 14, 2026, 3:38 PM EDT - Market open
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $365.29 million as of April 14, 2026. Its market cap has increased by 184.18% in one year.
Market Cap
365.29M
Enterprise Value
171.04M
1-Year Change
184.18%
Ranking
Category
Stock Price
$5.15
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $365.29M, a decrease of -37.82%. That is a compound annual growth rate of -7.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 394.38M | 351.16% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 468.25M |
| REGENXBIO | 464.56M |
| vTv Therapeutics | 461.63M |
| Lexeo Therapeutics | 460.82M |
| Assembly Biosciences | 459.70M |
| Atea Pharmaceuticals | 455.72M |
| Aura Biosciences | 449.05M |
| Sutro Biopharma | 448.48M |